Table 1 Characteristics of the study population
From: Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis
| Â | Sarcoidosis |
|---|---|
No. of subjects | 128 |
Men/Women | 34/94 |
Age, yr | 55(17–79) |
Cigarette smoking | 55/29/43 |
(never/former/current) | |
Radiograhical stage | 21/56/43/8 |
(0/I/II/III) | |
BALF findings | Â |
     Total cell counts, 104/mL | 18.1 (3.2–92.2) |
     Macrophages, % | 66.3 (6.0–97.0) |
     Lymphocytes, % | 32.8 (2.9–76.3) |
     CD4/CD8, ratio | 4.93 (0.65–30.16) |
Pulmonary function result | Â |
     VC, % predicted | 113.0 (70.5–153.7) |
     DLco, % predicted | 90.1 (37.0–142.0) |
Serum maker | Â |
     soluble IL-2 receptor, U/mL | 805 (117–4990) |
KL-6 levels | Â |
     BALF, U/mL | 296 (90–1507) |
     serum, U/mL | 336 (102–3091) |